直接到心脏:在化疗期间保护患者的心脏
Rachel Conyers1, David A Elliott2
1Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, VIC, Australia; Children's Cancer Centre, Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia; The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Parkville, VIC, Australia.
研究人员确定印苏拉姆作为一种潜在的心脏保护药物,可以在环素化疗期间保护心脏. 这一发现为缓解化疗治疗提供了希望.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
背景情况:
- 人环素是有效的化疗药物,但可能导致心脏毒性.
- 在治疗中保护心脏是重要的临床挑战.
研究的目的:
- 确定新的治疗策略,以预防由 antracycline 诱导的心脏毒性.
- 为了发现可以在化疗期间保护心脏功能的化合物.
主要方法:
- 利用了人类多能干细胞衍生的心肌细胞.
- 采用CRISPR基因查来识别保护性基因和通路.
- 应用分子建模来理解药物相互作用.
主要成果:
- 印苏拉姆被确定为一种化合物,可以保护心肌细胞免受环素诱导的损伤.
- 这项研究揭示了印迪苏拉姆心脏保护作用的潜在分子机制.
结论:
- 印西苏拉姆在接受 antracycline 化疗的患者中显示出作为心脏保护剂的前景.
- 需要进一步的研究来将这些发现转化为临床实践.
相关概念视频
Imaging Studies for Cardiovascular System V: CT
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Heart Failure Drugs: Inotropic Agents
Pericarditis IV: Nursing Management
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System


